Jeffrey Lee has more than three decades of experience working at the renowned cancer center. The new chief medical executive of University of Texas MD Anderson Cancer Center is committed to a ...

The trial, conducted by The University of Texas MD Anderson Cancer Center, showed a favorable safety profile and injection feasibility as well as a median overall survival (mOS) of 23 months from the ...